NASDAQ:CTMX | Cash Flow Statement | CytomX Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$20.67M
2026-03-31-$18.25M-$25.55M$0.00-$192.78M$234.49M
2025-12-31-$26.51M-$23.24M$201,000.00-$14.42M$16.64M
2025-09-30-$14.23M
2025-06-30-$154,000.00
2025-03-31$23.53M-$21.04M$119,000.00$30.6M$0.00
2024-12-31$18.88M-$19.91M$80,000.00$15.14M$2.25M
2024-09-30$5.74M
2024-06-30-$6.53M
2024-03-31$13.79M-$26.05M$115,000.00$44.89M$174,000.00
2023-12-31$837,000.00-$21.96M$266,000.00$12.87M$244,000.00
2023-09-30$2.99M
2023-06-30-$1.09M
2023-03-31-$3.31M$9.35M$48,000.00-$146.64M$0.00
2022-12-31-$8.78M-$1.39M$182,000.00$99.82M$190,000.00
2022-09-30-$29.06M
2022-06-30-$29.5M
2022-03-31-$31.98M-$41.31M$736,000.00-$736,000.00$7,000.00
2021-12-31-$58.49M-$31.19M$245,000.00-$245,000.00$683,000.00
2021-09-30-$22.58M
2021-06-30-$19.24M
2021-03-31-$15.55M-$29.94M$982,000.00$59.01M$108.74M
2020-12-31-$14.7M-$17.43M$445,000.00$19.46M$13.02M
2020-09-30-$14.71M
2020-06-30-$15.68M
2020-03-31$12.21M-$49.74M$1.05M$2.44M$2.16M
2019-12-31-$35.46M-$29.48M$703,000.00$52.86M$401,000.00
2019-09-30-$23.7M
2019-06-30-$28.96M
2019-03-31-$14.12M-$39.03M$1.84M-$18.61M$465,000.00
2018-12-31-$32.23M-$28.74M$1.12M$15.84M$724,000.00
2018-09-30-$23.43M
2018-06-30-$13.45M
2018-03-31-$15.49M-$14.61M$751,000.00-$23.38M$2.6M
2017-12-31$621,000.00$22M$234,000.00-$149.76M$21.08M
2017-09-30-$10.25M
2017-06-30-$25.22M
2017-03-31-$8.26M-$19.09M$944,000.00
2016-12-31-$14.03M$1.94M$602,000.00
2016-09-30-$14.66M
2016-06-30-$14.18M
2016-03-31-$16.03M-$5.54M$327,000.00
2015-12-31-$11.49M-$8.17M$182,000.00
2015-09-30-$11.87M
2015-06-30-$5.81M
2015-03-31-$6.21M-$5.37M$255,000.00
2014-12-31-$4.79M-$4.4M$664,000.00
2014-09-30-$3.59M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$17.37M-$75.59M$220,000.00-$59.74M$110.45M
2024-12-31$31.87M-$86.23M$310,000.00$99.7M$7.52M
2023-12-31-$569,000.00-$56.04M$840,000.00-$150.67M$30.23M
2022-12-31-$99.32M-$110.79M$1.74M$98.26M$648,000.00
2021-12-31-$115.87M-$119.03M$1.61M$22.49M$110.21M
2020-12-31-$32.89M$5.26M$2.31M-$18.72M$16.89M
2019-12-31-$102.24M-$140.48M$3.5M$79.7M$1.63M
2018-12-31-$84.6M-$75.52M$3.79M$5.93M$139.62M
2017-12-31-$43.1M$170.37M$1.56M-$121.27M$23.8M
2016-12-31-$58.9M-$2.03M$2.18M$45.86M$996,000.00
2015-12-31-$35.37M-$27.42M$1.59M
2014-12-31-$30.31M$31.8M$1.66M
2013-12-31-$15.14M-$8.01M$732,000.00